35628181|t|Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation.
35628181|a|Alzheimer's disease (AD) is associated with the accumulation and aggregation of amyloid in the brain. The cation channel TRPV2 may mediate the pathological changes in mild cognitive impairment. A high-affinity agonist of TRPV2 named cannabidiol is one of the candidate drugs for AD. However, the molecular mechanism of cannabidiol via TRPV2 in AD remains unknown. The present study investigated whether cannabidiol enhances the phagocytosis and clearance of microglial Abeta via the TRPV2 channel. We used a human dataset, mouse primary neuron and microglia cultures, and AD model mice to evaluate TRPV2 expression and the ability of microglial amyloid-beta phagocytosis in vivo and in vitro. The results revealed that TRPV2 expression was reduced in the cortex and hippocampus of AD model mice and AD patients. Cannabidiol enhanced microglial amyloid-beta phagocytosis through TRPV2 activation, which increased the mRNA expression of the phagocytosis-related receptors, but knockdown of TRPV2 or Trem2 rescued the expression. TRPV2-mediated effects were also dependent on PDK1/Akt signaling, a pathway in which autophagy was indispensable. Furthermore, cannabidiol treatment successfully attenuated neuroinflammation while simultaneously improving mitochondrial function and ATP production via TRPV2 activation. Therefore, TRPV2 is proposed as a potential therapeutic target in AD, while CBD is a promising drug candidate for AD.
35628181	0	11	Cannabidiol	Chemical	MESH:D002185
35628181	128	147	Alzheimer's disease	Disease	MESH:D000544
35628181	149	151	AD	Disease	MESH:D000544
35628181	208	215	amyloid	Disease	MESH:C000718787
35628181	249	254	TRPV2	Gene	51393
35628181	300	320	cognitive impairment	Disease	MESH:D003072
35628181	349	354	TRPV2	Gene	51393
35628181	361	372	cannabidiol	Chemical	MESH:D002185
35628181	407	409	AD	Disease	MESH:D000544
35628181	447	458	cannabidiol	Chemical	MESH:D002185
35628181	463	468	TRPV2	Gene	22368
35628181	472	474	AD	Disease	MESH:D000544
35628181	531	542	cannabidiol	Chemical	MESH:D002185
35628181	597	602	Abeta	Gene	351
35628181	611	616	TRPV2	Gene	22368
35628181	636	641	human	Species	9606
35628181	651	656	mouse	Species	10090
35628181	700	702	AD	Disease	MESH:D000544
35628181	709	713	mice	Species	10090
35628181	726	731	TRPV2	Gene	22368
35628181	773	785	amyloid-beta	Gene	351
35628181	847	852	TRPV2	Gene	22368
35628181	909	911	AD	Disease	MESH:D000544
35628181	918	922	mice	Species	10090
35628181	927	929	AD	Disease	MESH:D000544
35628181	930	938	patients	Species	9606
35628181	940	951	Cannabidiol	Chemical	MESH:D002185
35628181	972	984	amyloid-beta	Gene	351
35628181	1006	1011	TRPV2	Gene	22368
35628181	1116	1121	TRPV2	Gene	22368
35628181	1125	1130	Trem2	Gene	83433
35628181	1155	1160	TRPV2	Gene	51393
35628181	1201	1205	PDK1	Gene	228026
35628181	1206	1209	Akt	Gene	11651
35628181	1282	1293	cannabidiol	Chemical	MESH:D002185
35628181	1328	1345	neuroinflammation	Disease	MESH:D000090862
35628181	1404	1407	ATP	Chemical	MESH:D000255
35628181	1423	1428	TRPV2	Gene	22368
35628181	1452	1457	TRPV2	Gene	51393
35628181	1507	1509	AD	Disease	MESH:D000544
35628181	1517	1520	CBD	Chemical	MESH:D002185
35628181	1555	1557	AD	Disease	MESH:D000544
35628181	Negative_Correlation	MESH:D000544	22368
35628181	Positive_Correlation	MESH:D002185	51393
35628181	Association	11651	51393
35628181	Association	228026	51393
35628181	Positive_Correlation	MESH:D000255	MESH:D002185
35628181	Association	22368	351
35628181	Association	MESH:D000544	51393
35628181	Association	MESH:D003072	51393
35628181	Negative_Correlation	MESH:D002185	MESH:D000090862
35628181	Negative_Correlation	MESH:D002185	351
35628181	Positive_Correlation	MESH:D002185	22368
35628181	Negative_Correlation	MESH:D002185	MESH:D000544
35628181	Association	MESH:D000255	22368

